Literature DB >> 3748272

Subcellular fractionation and distribution of cholinergic binding sites in fetal human brain.

J Whyte, R Harrison, G G Lunt, S Wonnacott.   

Abstract

Conventional subcellular fractionation techniques have been applied to human fetal brain (13-15 weeks gestation) and the fractions have been characterized by assaying for marker enzymes, cholinergic binding sites and electron microscopy. Fractionation of the homogenate resulted in a nuclear pellet (P1), a crude mitochondrial pellet (P2) and a supernatant (S2). Further resolution of the P2 fraction by density gradient centrifugation resulted in two bands at the gradient interfaces and a pellet. The P2 and subsequently the P2B fraction contained intact plasma membrane profiles as judged by the predominance of adenylate cyclase activity and the presence of occluded lactate dehydrogenase which constituted over 70% of the total activity in these fractions. Morphological examination of the gradient fractions revealed that the P2B fraction contains membrane bound structures which resemble synaptosomes prepared from neonatal rat brain. These structures have a granular matrix in which mitochondria and frequently, neurofilaments were observed. Very few synaptic vesicles were present and there was no evidence for post synaptic attachments. The cholinergic markers choline acetyltransferase, acetylcholinesterase and receptor sites defined by quinuclidinyl benzilate and alpha-bungarotoxin binding were enriched in fractions P2 and P2B which contained the bulk of nerve ending particles. This enriched preparation of fetal synaptosomes may be valuable for functional studies on pre-synaptic terminals in developing brain.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3748272     DOI: 10.1007/bf00965590

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  46 in total

1.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.

Authors:  E G GRAY; V P WHITTAKER
Journal:  J Anat       Date:  1962-01       Impact factor: 2.610

2.  The postnatal development of the synapse: a morphological approach utilizing synaptosomes. I. General features.

Authors:  D G Jones; E Revell
Journal:  Z Zellforsch Mikrosk Anat       Date:  1970

3.  Synaptosomes prepared from fresh human cerebral cortex; morphology, respiration and release of transmitter amino acids.

Authors:  P Dodd; J A Hardy; A E Oakley; A J Strong
Journal:  Brain Res       Date:  1981-11-16       Impact factor: 3.252

4.  Synaptic development in the human fetus: a morphometric analysis of normal and Down's syndrome neocortex.

Authors:  T L Petit; J C LeBoutillier; D P Alfano; L E Becker
Journal:  Exp Neurol       Date:  1984-01       Impact factor: 5.330

Review 5.  Alpha-bungarotoxin binding and central nervous system nicotinic acetylcholine receptors.

Authors:  R E Oswald; J A Freeman
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

6.  Development of synaptic contacts in the human brain at early stages of embryogenesis.

Authors:  A Z Ivanshina
Journal:  Neurosci Behav Physiol       Date:  1977 Oct-Dec

7.  The osmotically sensitive potassium and sodium compartments of synaptosomes.

Authors:  R M Marchbanks
Journal:  Biochem J       Date:  1967-07       Impact factor: 3.857

8.  Neosurugatoxin blocks nicotinic acetylcholine receptors in the brain.

Authors:  C Rapier; R Harrison; G G Lunt; S Wonnacott
Journal:  Neurochem Int       Date:  1985       Impact factor: 3.921

9.  Cyclic AMP and adenyl cyclase in brain tumors.

Authors:  M A Furman; K Shulman
Journal:  J Neurosurg       Date:  1977-04       Impact factor: 5.115

10.  Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release.

Authors:  J A Hardy; P R Dodd; A E Oakley; A M Kidd; R H Perry; J A Edwardson
Journal:  Neurosci Lett       Date:  1982-12-13       Impact factor: 3.046

View more
  1 in total

Review 1.  Alzheimer's disease: Targeting the Cholinergic System.

Authors:  Talita H Ferreira-Vieira; Isabella M Guimaraes; Flavia R Silva; Fabiola M Ribeiro
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.